ASCENDE-RT: An Analysis of Treatment-Related Morbidity for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost with a Dose-Escalated External Beam Boost for High- and Intermediate-Risk Prostate Cancer

S. Rodda, Scott Tyldesley, William Morris, Mira Keyes, Ross Halperin, Howard Pai, Michael McKenzie, Graeme Duncan, Gerard Morton, Jeremy Hamm

Type: Article

Publication Date: 2017-01-07

Citations: 275

DOI: https://doi.org/10.1016/j.ijrobp.2017.01.008

View Publication

Download PDF

Locations

International Journal of Radiation Oncology*Biology*Physics - View - PDF
PubMed - View

Similar Works

Action	Title	Year	Authors
+	High-Risk Prostate Cancer: Local Therapy Matters	2015	Adam L. Liss Daniel A. Hamstra
+	Dose Escalation for Prostate Adenocarcinoma: A Long-Term Update on the Outcomes of a Phase 3, Single Institution Randomized Clinical Trial	2019	Dario Pasalic Deborah A. Kuban Pamela K. Allen Chad Tang Shane Mesko Stephen R. Grant Alexander Augustyn Steven J. Frank Seungtaek Choi Karen E. Hoffman
+ PDF Chat	Combined Modality Therapies for High-Risk Prostate Cancer: Narrative Review of Current Understanding and New Directions	2019	Benjamin A. Greenberger Victor E. Chen Robert B. Den
+ PDF Chat	Long-term tolerance and outcomes for dose escalation in early salvage post-prostatectomy radiation therapy	2014	Joseph Safdieh David A. Schwartz Joseph Weiner Jeffrey P. Weiss Justin Rineer Isaac Madeb Marvin Rotman David Schreiber
+	Re: Sebastian Berg, Alexander P. Cole, Marieke J. Krimphove, et al. Comparative Effectiveness of Radical Prostatectomy Versus External Beam Radiation Therapy Plus Brachytherapy in Patients with High-risk Localized Prostate Cancer. Eur Urol 2019;75:552–5	2019	Michael Froehner Christian Thomas
+	Re: Sebastian Berg, Alexander P. Cole, Marieke J. Krimphove, et al. Comparative Effectiveness of Radical Prostatectomy Versus External Beam Radiation Therapy Plus Brachytherapy in Patients with High-risk Localized Prostate Cancer. Eur Urol 2019;75:552–5	2019	Amar U. Kishan William A. Hall Daniel E. Spratt
+ PDF Chat	Addition of Androgen-Deprivation Therapy or Brachytherapy Boost to External Beam Radiotherapy for Localized Prostate Cancer: A Network Meta-Analysis of Randomized Trials	2020	Will Jackson Holly Hartman Robert T. Dess Sam R. Birer Payal Soni Jason W.D. Hearn Zachary Reichert Amar U. Kishan Brandon A. Mahal Zachary S. Zumsteg
+	Re: Surrogate End Points for All-Cause Mortality in Men with Localized Unfavorable-Risk Prostate Cancer Treated with Radiation Therapy vs Radiation Therapy plus Androgen Deprivation Therapy: A Secondary Analysis of a Randomized Clinical Trial	2017	David F. Penson
+	Comparing Radiotherapy to Prostatectomy for High-Risk Prostate Cancer	2020	Benjamin A. Greenberger James M. Taylor Victor E. Chen Robert B. Den
+	Re: Rhonda L. Bitting, Patrick Healy, Daniel J. George, et al. Phase II Trial of Enzalutamide and Androgen Deprivation Therapy with Salvage Radiation in Men with High-risk Prostate-specific Antigen Recurrent Prostate Cancer: The STREAM Trial. Eur Urol Oncol 2021;4:948–54	2022	Ozan Cem Güler Oguzhan Isci Cem Önal
+	A Phase II Trial of Varian Trilogy-based SBRT for Low-risk Prostate Cancer: Report of Early Toxicity and Disease Control Outcomes	2009	C.A. Mantz Eduardo B. Fernández Isaac Zucker S. Harrison
+ PDF Chat	Prospective Phase 2 Trial of Permanent Seed Implantation Prostate Brachytherapy for Intermediate-Risk Localized Prostate Cancer: Efficacy, Toxicity, and Quality of Life Outcomes	2017	Steven J. Frank Thomas J. Pugh Pierre Blanchard Usama Mahmood William Graber Rajat J. Kudchadker John W. Davis Jeri Kim Haesun Choi Patricia Troncoso
+ PDF Chat	A New Method for Synthesizing Radiation Dose–Response Data From Multiple Trials Applied to Prostate Cancer	2009	Patricia Díez Ivan R. Vogelius Søren M. Bentzen
+	Why Stop at Using High-Dose-Rate Brachytherapy as a Boost for the Prostate?	2000	Jonathan J. Beitler
+ PDF Chat	Comparison of Multimodal Therapies and Outcomes Among Patients With High-Risk Prostate Cancer With Adverse Clinicopathologic Features	2021	Amar U. Kishan R. Jeffrey Karnes Tahmineh Romero J.K. Wong Giovanni Motterle Jeffrey J. Tosoian Bruce J. Trock Eric A. Klein Bradley J. Stish Robert T. Dess
+ PDF Chat	Multimodal treatment for high-risk prostate cancer with high-dose intensity-modulated radiation therapy preceded or not by radical prostatectomy, concurrent intensified-dose docetaxel and long-term androgen deprivation therapy: results of a prospective phase II trial	2014	Andrea Guttilla Roberto Bortolus Gianluca Giannarini Pirus Ghadjar Fabio Zattoni Michele Gnech Vito Palumbo Francesca Valent A. Garbeglio Filiberto Zattoni
+	Active surveillance versus nonradical treatment for low-risk men with prostate cancer: a review	2022	Sachin Perera J.A. McDonald Isabella S.C. Williams J O’Brien Declan Murphy Nathan Lawrentschuk
+	Comparative Evaluation of Radiation Treatments for Clinically Localized Prostate Cancer: An Updated Systematic Review	2011	Raveendhara R. Bannuru Tomáš Dvořák Ndidiamaka Obadan Winifred W Yu Kamal Patel Mei Chung Stanley Ip
+	The ASTRO consensus definition of bNED failure is an inappropriate endpoint for prostate cancer patients receiving conformal radiation therapy and androgen deprivation (CRT+AD)	1998	AM Slivjak WH Pinover A. Hanlon E. Horwitz Hanks Ge
+ PDF Chat	Stereotactic Ablative Radiation and Short-Term Androgen Ablation for Intermediate-Risk Localized Prostate Adenocarcinoma: Safety and Toxicity From a Prospective Single-Arm Phase II Trial (NCT01517451)	2019	Ryan Phillips Hamza Hasan J. Huang S. Di Pasquale Raman Kumar Matthew P. Deek Colburn Yu Theodore L. DeWeese Misop Han Michael A. Gorin

Works That Cite This (11)

Action	Title	Year	Authors
+ PDF Chat	Direct Comparison of Low-Dose-Rate Brachytherapy Versus Radical Prostatectomy Using the Surgical Definition of Biochemical Recurrence for Patients with Intermediate-Risk Prostate Cancer	2022	Hideyasu Tsumura Nobumichi Tanaka Tomohiko Oguchi Takuya Owari Yasushi Nakai Isao Asakawa Kazuyoshi Iijima Haruaki Kato Iwao Hashida Ken‐ichi Tabata
+ PDF Chat	Tolerability of concurrent external beam radiotherapy and [177Lu]Lu-PSMA-617 for node-positive prostate cancer in treatment naïve patients, phase I study (PROQURE-I trial)	2023	Esmée C. A. van der Sar Arthur J. A. T. Braat Jochem R.N. van der Voort van Zyp Betty S. van der Veen Pim J. van Leeuwen Daphne M. V. Huizing Jeroen M. A. Hendrikx Marnix G. E. H. Lam Wouter V. Vogel
+	Optimal Radical Therapy for Localized Prostate Cancer: Recreation of the Self-Fulfilling Prophecy With Combination Brachytherapy?	2018	Daniel E. Spratt Peter R. Carroll
+ PDF Chat	<p>The Impact of Prostate Cancer Treatment on Quality of Life: A Narrative Review with a Focus on Randomized Data</p>	2020	James M. Taylor Victor E. Chen C. Ryan Miller Benjamin A. Greenberger
+	Randomized Trials and the Goldilocks Problem	2019	Ronald C. Chen
+	Microboost in Localized Prostate Cancer: Analysis of a Statewide Quality Consortium	2024	Samuel N. Regan Michael Dykstra Huiying Yin Margaret N. Grubb Neil Vaishampayan Mark Zaki M. Mislmani Patrick A. McLaughlin Danielle Kendrick Stephen R. Miller
+ PDF Chat	A Review on the Current Treatment Paradigm in High-Risk Prostate Cancer	2021	Laura Burgess Soumyajit Roy Scott C. Morgan Shawn Malone
+	Local Failure in High-grade Prostate Cancer: An Elusive but Important Outcome and Target for Clinical Trials	2019	Shabbir M.H. Alibhai Padraig Warde
+	Advances in high-risk localized prostate cancer: Staging and management	2023	Yeison A Reina Catalina Villaquirán Herney Andrés García‐Perdomo
+	Approach to Patients with High-Risk Localized Prostate Cancer: Radiation Oncology Perspective	2024	Sophia C. Kamran Neha Vapiwala

Works Cited by This (1)

Action	Title	Year	Authors
+	Long-term results of the Dutch randomized prostate cancer trial: Impact of dose-escalation on local, biochemical, clinical failure, and survival	2013	Wilma D. Heemsbergen Abrahim Al‐Mamgani Annerie Slot Michel F.H. Dielwart Joos V. Lebesque